Treatment of HIV/AIDs has evolved greatly since the disease's emergence in 1981. When antiretrovirals were first introduced, almost every patient developed drug resistance within the first year of drug use. Today, however, ...
Mar 7, 2016
0
51
The microbiome offers a motherlode of data about health and disease, and new findings suggest that antibodies to gut microbes can determine how well patients respond to a new monoclonal antibody drug that delays the onset ...
An international team of scientists, including four at Simon Fraser University, has made a discovery that will change the way the most deadly form of breast cancer is treated.
Apr 4, 2012
1
0
Neurologists must make sure Alzheimer's patients and their families understand that the controversial drug aducanumab does not restore mental function, the American Academy of Neurology (AAN) said in new position statement ...
Nov 18, 2021
0
11
A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill clinical trials and enroll sufficiently diverse groups of patients for results to reflect the broader population, in ...
Aug 5, 2022
0
20
Several studies have reported a lack of gender diversity in clinical trials, with trials including mostly adult males; however, a recent review of publicly available registration data of clinical trials at the US Food and ...
Jan 11, 2018
0
2
Researchers have developed a new technique to identify hotspots of malaria parasite evolution and track the rise of malarial drug resistance, faster and more efficiently than ever before.
Jun 13, 2012
0
0
(HealthDay)—U.S. health care organizations lost nearly $454 million due to clinical drug diversion in 2018, according to the 2019 Drug Diversion Digest, released by Protenus Inc.
May 21, 2019
0
0
Black patients are still underrepresented in most trials relating to approval of new drugs, despite implementation of an action plan in 2015 to improve diversity, according to a report published in the March issue of Health ...
Mar 14, 2022
3
18
Populations underrepresented in clinical trials face worse health outcomes that will cost the U.S. trillions of dollars over the next three decades, according to a new report from the National Academies of Science, Engineering ...
May 19, 2022
0
2
